Pimozide
Sponsors
Universitair Medisch Centrum Groningen, Fundacion Para La Gestion De La Investigacion En Salud De Sevilla, National Center for Research Resources (NCRR), Icahn School of Medicine at Mount Sinai, Yale University
Conditions
Anxiety DisordersDementiaDepressionDrug-induced QT ProlongationHAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosisPharmacodynamicsPharmacokineticsPsychosomatic Disorders
Phase 1
Phase 2
Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
CompletedNCT00004652
Start: 1993-02-28Target: 20Updated: 2005-06-24
Efficacy of Pimozide Augmentation for Clozapine Partial Response
CompletedNCT00374244
Start: 2004-01-31End: 2011-06-30Updated: 2016-03-04
Cognitive effects of adjuntive Vortioxetine in early Schizophrenia
Not yet recruitingCTIS2024-519778-38-00
Target: 37Updated: 2025-03-06
Phase 3
Phase 4
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
CompletedNCT00158223
Start: 2004-10-31End: 2009-02-28Updated: 2015-04-09
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
CompletedNCT02307396
Start: 2015-02-01End: 2016-06-22Updated: 2018-10-11
HAMLETT; Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis
Not yet recruitingCTIS2024-518769-80-00
Target: 444Updated: 2024-11-25